Cargando…
Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study
OBJECTIVES: Patients with vascular anomalies (VAs) who receive oral sirolimus may be at high risk of infectious complications. Antibiotic prophylaxis with trimethoprim-sulfamethoxazole (TMP-SMZ) has been advocated. However, there have been few evidence-based analyses on this topic. This study assess...
Autores principales: | Qiu, Tong, Li, Yanan, Gong, Xue, Zhou, Jiangyuan, Yang, Kaiying, Zhang, Xuepeng, Zhang, Zixin, Lan, Yuru, Hu, Fan, Peng, Qiang, Zhang, Yongbo, Kong, Feiteng, Chen, Siyuan, Ji, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207744/ https://www.ncbi.nlm.nih.gov/pubmed/37221564 http://dx.doi.org/10.1186/s13023-023-02740-3 |
Ejemplares similares
-
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021) -
Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review
por: Zhang, Zixin, et al.
Publicado: (2022) -
Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management
por: Ji, Yi, et al.
Publicado: (2020) -
Impact of age and tumor size on the development of the Kasabach–Merritt phenomenon in patients with kaposiform hemangioendothelioma: a retrospective cohort study
por: Zhou, Jiangyuan, et al.
Publicado: (2023) -
Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma
por: Yang, Kaiying, et al.
Publicado: (2023)